MSFT 419.78 0.4234% AAPL 225.36 0.5039% NVDA 149.123 2.6594% GOOGL 180.02 -0.183% GOOG 181.75 -0.1209% AMZN 206.566 -0.1325% META 583.0 -0.0292% AVGO 176.035 -1.607% TSLA 339.0599 -3.1257% TSM 191.05 -1.546% LLY 813.99 -2.2164% V 308.82 -0.4866% JPM 239.89 0.2507% UNH 615.58 -1.5466% NVO 105.956 -2.8729% WMT 84.965 0.8966% LVMUY 120.91 -5.0793% XOM 120.78 0.2573% LVMHF 605.0 -5.1263% MA 529.85 -0.0509%
Last update at 2024-11-12T16:47:00Z
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Trading At A 44% Discount?
Mon 21 Oct 24, 11:00 AMThe Smartest Growth Stock to Buy With $500 Right Now
Sat 19 Oct 24, 12:00 AMVertex Pharmaceuticals (VRTX) Ascends But Remains Behind Market: Some Facts to Note
Mon 14 Oct 24, 10:00 PMGot $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever
Sun 13 Oct 24, 01:00 PMVertex Pharmaceuticals Inc (VRTX) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...
Wed 09 Oct 24, 07:50 PM2 Biotech Stocks to Buy Hand Over Fist in October
Wed 09 Oct 24, 12:00 AMVertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
Mon 07 Oct 24, 10:00 PMZacks Market Edge Highlights: Vertex, Zillow RH, Super Micro Computer, Yum China
Mon 07 Oct 24, 09:08 AMInsider Trades: How to Find the Top Stocks
Fri 04 Oct 24, 05:23 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 4232.40M | 2730.40M | 3116.80M | 1394.92M | 600.24M |
Minority interest | - | - | 0.00000M | 0.00000M | -9.79300M |
Net income | 3322.00M | 2342.10M | 2711.65M | 1176.81M | 2096.90M |
Selling general administrative | 887.20M | 840.10M | 770.46M | 658.50M | 557.62M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 7850.40M | 6670.20M | 5469.38M | 3615.06M | 2638.06M |
Reconciled depreciation | 148.30M | 125.60M | 109.52M | 106.94M | 72.42M |
Ebit | 4307.40M | 2782.10M | 2856.29M | 1197.57M | 590.76M |
Ebitda | 4345.20M | 2788.80M | 3188.05M | 1457.88M | 663.18M |
Depreciation and amortization | 37.80M | 6.70M | 331.76M | 260.31M | 72.42M |
Non operating income net other | -20.20000M | 9.80M | 318.66M | 255.85M | -0.79000M |
Operating income | 4307.40M | 2782.10M | 2856.29M | 1197.57M | 635.15M |
Other operating expenses | 4565.30M | 4795.40M | 3336.29M | 2960.80M | 2383.63M |
Interest expense | 54.80M | 61.50M | 58.15M | 58.50M | 34.12M |
Tax provision | 910.40M | 388.30M | 405.15M | 218.11M | -1486.86200M |
Interest income | 144.60M | 4.90M | 22.24M | 63.68M | 33.50M |
Net interest income | 89.80M | -56.60000M | -35.91200M | 5.18M | -34.11900M |
Extraordinary items | - | - | - | - | 1560.00M |
Non recurring | 115.50M | - | - | - | 28.82M |
Other items | - | - | - | - | - |
Income tax expense | 910.40M | 388.30M | 405.15M | 218.11M | -1486.86200M |
Total revenue | 8930.70M | 7574.40M | 6205.68M | 4162.82M | 3047.60M |
Total operating expenses | 3485.00M | 3891.20M | 2599.99M | 2413.04M | 1974.09M |
Cost of revenue | 1080.30M | 904.20M | 736.30M | 547.76M | 409.54M |
Total other income expense net | -75.00000M | -51.70000M | 260.51M | 197.35M | -29.60600M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 3322.00M | 2342.10M | 2711.65M | 1176.81M | 2087.10M |
Net income applicable to common shares | 3322.00M | 2342.10M | 2711.65M | 1176.81M | 2096.90M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 22730.20M | 18150.90M | 13432.50M | 11751.81M | 8318.47M |
Intangible assets | 839.90M | 603.60M | 400.00M | 400.00M | 400.00M |
Earning assets | - | - | - | - | - |
Other current assets | 620.50M | 74.40M | 187.20M | 308.35M | 213.51M |
Total liab | 5149.80M | 4238.20M | 3332.50M | 3064.99M | 2233.22M |
Total stockholder equity | 17580.40M | 13912.70M | 10100.00M | 8686.82M | 6085.24M |